Taking parameter uncertainty into account is key to make drug development decisions such as testing whether trial endpoints meet defined criteria. Currently used methods for assessing parameter uncertainty in NLMEM have limitations, and there is a lack of diagnostics for when these limitations occur. In this work, a method based on sampling importance resampling (SIR) is proposed, which has the advantage of being free of distributional assumptions and does not require repeated parameter estimation. To perform SIR, a high number of parameter vectors are simulated from a given proposal uncertainty distribution. Their likelihood given the true uncertainty is then approximated by the ratio between the likelihood of the data given each vector an...
International audienceThis article focuses on parameter estimation of multilevel nonlinear mixed-eff...
120 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2000.The general goal of this stud...
Introduction. Patient-level simulation models facilitate extrapolation of clinical trial data while ...
Taking parameter uncertainty into account is key to make drug development decisions such as testing ...
Quantifying the uncertainty around endpoints used for decision-making in drug development is essenti...
Knowledge of the uncertainty in model parameters is essential for decision-making in drug developmen...
International audienceBootstrap methods are used in many disciplines to estimate the uncertainty of ...
Pharmacometric model-based analysis using nonlinear mixed-effects models (NLMEM) has to date mainly ...
International audienceA version of the nonparametric bootstrap, which resamples the entire subjects ...
International audienceData below the quantification limit (BQL data) are a common challenge in data ...
In the framework of Mixed Models, it is often of interest to provide an estimate of the uncertainty ...
Multi-parameter models in systems biology are typically ‘sloppy’: some parameters or combinations of...
Standard statistical decision-making tools, such as inference, confidence intervals and forecasting,...
International audienceThis article focuses on parameter estimation of multilevel nonlinear mixed-eff...
120 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2000.The general goal of this stud...
Introduction. Patient-level simulation models facilitate extrapolation of clinical trial data while ...
Taking parameter uncertainty into account is key to make drug development decisions such as testing ...
Quantifying the uncertainty around endpoints used for decision-making in drug development is essenti...
Knowledge of the uncertainty in model parameters is essential for decision-making in drug developmen...
International audienceBootstrap methods are used in many disciplines to estimate the uncertainty of ...
Pharmacometric model-based analysis using nonlinear mixed-effects models (NLMEM) has to date mainly ...
International audienceA version of the nonparametric bootstrap, which resamples the entire subjects ...
International audienceData below the quantification limit (BQL data) are a common challenge in data ...
In the framework of Mixed Models, it is often of interest to provide an estimate of the uncertainty ...
Multi-parameter models in systems biology are typically ‘sloppy’: some parameters or combinations of...
Standard statistical decision-making tools, such as inference, confidence intervals and forecasting,...
International audienceThis article focuses on parameter estimation of multilevel nonlinear mixed-eff...
120 p.Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2000.The general goal of this stud...
Introduction. Patient-level simulation models facilitate extrapolation of clinical trial data while ...